🇮🇳IN
Sign In
ER

ERIS

NSE

Eris Lifesciences Ltd

₹1,095.50

-25.70(-2.29%)

Ownership Score

Index Membership

and the weight we carry

Mutual Fund Ownership

% of each scheme's portfolio

Insider & Deals

who traded, and how close they are to the company

Ownership & Influence

who holds it, and what else they hold

Shared directors

companies with a board member in common

ERIS shareholding summary

As of Jun 2026, promoters held 54.14% of Eris Lifesciences Ltd (up 0.22 points from Mar 2026). Institutions together held 26.47%, of which foreign institutional investors held 5.76% (down 0.63 points from Mar 2026) and domestic institutions held 20.71% (up 0.36 points from Mar 2026). The public held the remaining 19.39% (up 0.06 points from Mar 2026). The company had 50,798 shareholders.

Promoters54.14%
FII5.76%
DII20.71%
Public19.39%

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer